|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$94,246.65 |
3.05% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$91,188.36 |
2.95% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$87,699.56 |
2.84% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$82,968.99 |
2.69% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,291.35 |
2.67% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$81,081.01 |
2.63% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$80,269.11 |
2.60% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$79,422.51 |
2.57% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$78,454.80 |
2.54% |
| Waters Corporation |
WAT |
941848103 |
184 |
$77,579.92 |
2.51% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$77,267.91 |
2.50% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$76,871.10 |
2.49% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$73,759.68 |
2.39% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$73,329.40 |
2.38% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$71,983.95 |
2.33% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,119.08 |
2.24% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$67,132.50 |
2.17% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$66,812.82 |
2.16% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$66,115.81 |
2.14% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$65,620.08 |
2.13% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$65,661.10 |
2.13% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$63,525.17 |
2.06% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$63,685.82 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,654.40 |
2.03% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$62,279.88 |
2.02% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$62,010.96 |
2.01% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$60,362.88 |
1.96% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$60,334.68 |
1.95% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$58,047.42 |
1.88% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$57,793.30 |
1.87% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,387.64 |
1.83% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,532.80 |
1.83% |
| Steris Plc |
STE |
G8473T100 |
265 |
$54,335.60 |
1.76% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,752.91 |
1.68% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,437.44 |
1.67% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$51,132.90 |
1.66% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$50,187.40 |
1.63% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$49,360.54 |
1.60% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$48,391.84 |
1.57% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$48,300.16 |
1.56% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$47,870.88 |
1.55% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$46,185.25 |
1.50% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$45,895.87 |
1.49% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$45,780.12 |
1.48% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,545.14 |
1.44% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,403.30 |
1.37% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$42,180.00 |
1.37% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$41,389.70 |
1.34% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$40,539.18 |
1.31% |
| US Dollar |
$USD |
|
12,931 |
$12,931.05 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|